<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Sudhir Srivastava -->
          <cik>0001570020</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>3</amendmentNo>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>03/31/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001676163</issuerCik>
        <issuerName>SS Innovations International, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>05453U203</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>1600 SE 15th Street,</com:street1>
          <com:street2>#512 Fort</com:street2>
          <com:city>Lauderdale</com:city>
          <com:stateOrCountry>FL</com:stateOrCountry>
          <com:zipCode>33316</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Sudhir Srivastava, M.D.</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>114490054.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>114490054.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>114490054.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>55.8</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Consists of (a) 109,585,767 shares of Common Stock of the Company held by Sushruta PVT LTD; (b) 32,000 shares of Common Stock of the Company held by Dr. Srivastava; and (c) Options held by Dr. Srivastava to purchase 4,872,287 shares of Common Stock of the Company. Dr. Srivastava has a 100% interest in Sushruta PVT LTD. Percentage in Row 11 is calculated based on 200,231,535 shares of common stock outstanding as of March 9, 2026, as reported in the issuer's Amended Annual Report on Form 10-K/A for the year ended December 31, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Sushruta PVT LTD</reportingPersonName>
      <citizenshipOrOrganization>C5</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>109585767.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>109585767.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>109585767.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>54.7</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>Row 5 and Row 7 consists of  109,585,767 shares of Common Stock of the Company held by Sushruta PVT LTD. Percentage in Row 11 is calculated based on 200,231,535 shares of common stock outstanding as of March 9, 2026, as reported in the issuer's Amended Annual Report on Form 10-K/A for the year ended December 31, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>SS Innovations International, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>1600 SE 15th Street, #512 Fort Lauderdale, FL 33316</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>(1) Sudhir Srivastava, M.D. (2) Sushruta PVT LTD</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The address for Sudhir Srivastava, M.D., Sushruta PVT LTD and Sudhir Srivastava Innovations PTE LTD is as follows: 1600 SE 15th Street, #512 Fort Lauderdale, FL 33316</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Sudhir Srivastava, M.D. - USA Sushruta PVT LTD - Commonwealth of the Bahamas</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>(1) Sudhir Srivastava, M.D. - 114,490,054 (2) Sushruta PVT LTD - 109,585,767</amountBeneficiallyOwned>
        <classPercent>(1) Sudhir Srivastava, M.D. - 55.8% (2) Sushruta PVT LTD - 54.7%. All calculations of percentage ownership herein are based upon an aggregate of 200,231,535 shares of common stock outstanding as of March 9, 2026, as reported in the issuer's Amended Annual Report on Form 10-K/A for the year ended December 31, 2025.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>(1) Sudhir Srivastava, M.D. - 114,490,054 (2) Sushruta PVT LTD - 109,585,767</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>(1) Sudhir Srivastava, M.D. - 0 (2) Sushruta PVT LTD - 0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>(1) Sudhir Srivastava, M.D. - 114,490,054 (2) Sushruta PVT LTD - 109,585,767</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>(1) Sudhir Srivastava, M.D. - 0 (2) Sushruta PVT LTD - 0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>N</notApplicableFlag>
        <subsidiaryIdentificationAndClassification>The shares of common stock referenced in Item 4, Section (a) above include shares held of record by Sushruta PVT LTD. Dr. Srivastava owns a 100% beneficial interest in Sushruta PVT LTD.</subsidiaryIdentificationAndClassification>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <exhibitInfo>JOINT FILING AGREEMENT</exhibitInfo>
    <signatureInformation>
      <reportingPersonName>Sudhir Srivastava, M.D.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Sudhir Srivastava</signature>
        <title>Sudhir Srivastava, M.D.</title>
        <date>05/04/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Sushruta PVT LTD</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Sudhir Srivastava</signature>
        <title>Sudhir Srivastava, M.D., Authorized Signatory</title>
        <date>05/04/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>

</edgarSubmission>
